A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy.

Bari, Rafijul; Granzin, Markus; Tsang, Kam Sze; Roy, Andre; Krueger, Winfried; Orentas, Rimas; Schneider, Dina; Pfeifer, Rita; Moeker, Nina; Verhoeyen, Els; Dropulic, Boro; Leung, Wing

Bari, Rafijul; Granzin, Markus; Tsang, Kam Sze; Roy, Andre; Krueger, Winfried; Orentas, Rimas; Schneider, Dina; Pfeifer, Rita; Moeker, Nina; Verhoeyen, Els; Dropulic, Boro; Leung, Wing.

Afiliação

Bari R; Lentigen, a Miltenyi Biotec Company, Miltenyi Biotec Company, Gaithersburg, MD, United States.
Granzin M; Miltenyi Biotec Inc, Gaithersburg, MD, United States.
Tsang KS; Miltenyi Biotec Inc, Gaithersburg, MD, United States.
Roy A; Lentigen, a Miltenyi Biotec Company, Miltenyi Biotec Company, Gaithersburg, MD, United States.
Krueger W; Lentigen, a Miltenyi Biotec Company, Miltenyi Biotec Company, Gaithersburg, MD, United States.
Orentas R; Lentigen, a Miltenyi Biotec Company, Miltenyi Biotec Company, Gaithersburg, MD, United States.
Schneider D; Lentigen, a Miltenyi Biotec Company, Miltenyi Biotec Company, Gaithersburg, MD, United States.
Pfeifer R; Miltenyi Biotec, Bergisch Gladbach, Germany.
Moeker N; Miltenyi Biotec, Bergisch Gladbach, Germany.
Verhoeyen E; CIRI, Université de Lyon 1, INSERM U1111, CNRS UMR 5308, ENS de Lyon, Lyon, France.
Dropulic B; Université Côte d'Azur, INSERM U1065, C3M, Nice, France.
Leung W; Lentigen, a Miltenyi Biotec Company, Miltenyi Biotec Company, Gaithersburg, MD, United States.